India's Sun Pharma Plots $12 Billion Organon Buyout For Global Reach [Yahoo! Finance Canada]
Fortress Biotech, Inc. (FBIO)
Last fortress biotech, inc. earnings: 11/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
fortressbiotech.com
Company Research
Source: Yahoo! Finance Canada
Most Read from Bloomberg India's largest drugmaker will pay $14 per Organon share in cash, giving the New Jersey-based company an enterprise valuation of $11.75 billion, according to a joint statement. The deal represents a 60% premium to Organon's closing price on Jan. 16, before news of takeover interest emerged. Organon's stock jumped 15% in pre-market trading to just shy of $13. The company specializes in women's health, with a portfolio spanning breast cancer, contraception, osteoporosis and menopause. The deal marks the culmination of Sun Pharma's decades-long evolution from a generics powerhouse into a global specialty player. The acquisition accelerates a strategic pivot toward high-value, branded drug segments, including dermatology, ophthalmology and oncology — a transition bolstered by previous key assets such as Taro Pharmaceutical Industries Ltd. and Checkpoint Therapeutics Inc. Should it go through, the deal will propel Mumbai-based Sun Pharma into the ranks of
Show less
Read more
Impact Snapshot
Event Time:
FBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FBIO alerts
High impacting Fortress Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
FBIO
News
- Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy Organon In Deal Valued At $11.8 Billion [Forbes]Forbes
- Fortress Biotech Reports 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million [Yahoo! Finance]Yahoo! Finance
- Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 MillionGlobeNewswire
- Fortress Biotech (FBIO) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
FBIO
Analyst Actions
- 2/23/26 - HC Wainwright
FBIO
Sec Filings
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form DEF
- 4/1/26 - Form 4
- FBIO's page on the SEC website